Ultra-high performance supercritical fluid chromatography coupled to tandem mass spectrometry for antidoping analyses: Assessment of the inter-laboratory reproducibility with urine samples.

anti‐doping analyses inter‐laboratory reproducibility tandem mass spectrometry ultra high‐performance supercritical fluid chromatography

Journal

Analytical science advances
ISSN: 2628-5452
Titre abrégé: Anal Sci Adv
Pays: Germany
ID NLM: 9918334986206676

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 26 10 2020
revised: 26 11 2020
accepted: 26 11 2020
medline: 5 12 2020
pubmed: 5 12 2020
entrez: 8 5 2024
Statut: epublish

Résumé

The aim of this study was to assess the interlaboratory reproducibility of ultra-high performance supercritical fluid chromatography coupled with tandem mass spectrometry method for routine antidoping analyses. To do so, a set of 21 doping agents, spiked in urine and analyzed after dilute and shoot treatment, was used to assess the variability of their retention times between four different laboratories, all equipped with the same chromatographic system and with the same ultra-high performance supercritical fluid chromatography stationary phase chemistry. The average relative standard deviations (RSD%) demonstrated a good reproducibility of the retention times for 19 out of 21 analytes, with RSD% values below 3.0%. Only for two substances, namely fenbutrazate and niketamide, the retention was not repeatable between laboratories, with RSD% of approximately 15% in both cases. This behaviour was associated with (a) the low organic modifier percentage (around 2-4%) in the mobile phase at the corresponding retention times, and (b) the influence of the system volume on poorly retained analytes. An analysis on seven "blind" urines was subsequently carried out in the same four laboratories. In these blind samples, either one, two, or none of the 21 doping agents previously analyzed were present at an unknown concentration. Each laboratory had to perform the identification of the compounds in the samples and estimate their concentrations. All laboratories assigned all target analytes correctly in all blind urine samples and provide a comparable estimation of their concentrations.

Identifiants

pubmed: 38715742
doi: 10.1002/ansa.202000131
pii: ANSA202000131
pmc: PMC10989559
doi:

Types de publication

Journal Article

Langues

eng

Pagination

68-75

Informations de copyright

© 2020 The Authors. Analytical Science Advances published by Wiley‐VCH GmbH.

Auteurs

Gioacchino Luca Losacco (GL)

School of Pharmaceutical Sciences University of Geneva CMU - Rue Michel-Servet 1 Geneva 4 1211 Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland University of Geneva CMU - Rue Michel-Servet 1 Geneva 1211 Switzerland.

Marco Rentsch (M)

Waters AG Taefernstrasse 14a Baden-Daetwill 5405 Switzerland.

Kateřina Plachká (K)

Department of Analytical Chemistry Faculty of Pharmacy in Hradec Králové Charles University Heyrovského 1203 Hradec Králové 500 05 Czech Republic.

Fabrice Monteau (F)

LABERCA Oniris, INRAE Nantes F-44307 France.

Emmanuelle Bichon (E)

LABERCA Oniris, INRAE Nantes F-44307 France.

Bruno Le Bizec (BL)

LABERCA Oniris, INRAE Nantes F-44307 France.

Lucie Nováková (L)

Department of Analytical Chemistry Faculty of Pharmacy in Hradec Králové Charles University Heyrovského 1203 Hradec Králové 500 05 Czech Republic.

Raul Nicoli (R)

Swiss Laboratory for Doping Analyses University Center of Legal Medicine Lausanne-Geneva, Centre Hospitalier Universitaire Vaudois, University of Lausanne Chemin des Croisettes 22 Epalinges 1066 Switzerland.

Tiia Kuuranne (T)

Swiss Laboratory for Doping Analyses University Center of Legal Medicine Lausanne-Geneva, Centre Hospitalier Universitaire Vaudois, University of Lausanne Chemin des Croisettes 22 Epalinges 1066 Switzerland.

Jean-Luc Veuthey (JL)

School of Pharmaceutical Sciences University of Geneva CMU - Rue Michel-Servet 1 Geneva 4 1211 Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland University of Geneva CMU - Rue Michel-Servet 1 Geneva 1211 Switzerland.

Davy Guillarme (D)

School of Pharmaceutical Sciences University of Geneva CMU - Rue Michel-Servet 1 Geneva 4 1211 Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland University of Geneva CMU - Rue Michel-Servet 1 Geneva 1211 Switzerland.

Classifications MeSH